This opens up a substantially larger market to go after now at final approval is in.
The revenues will continue to surge.
EU revenue will be included this quarter.
Current total available patient population is now 10,000.
Add a few thousand more for Japan.
EU sales coming on line now.
EU coming on line now.
It will be interesting to see how much EU revenue comes in this quarter.